Načítá se...
Efficacy and safety of iron isomaltoside (Monofer(®)) in the management of patients with iron deficiency anemia
New intravenous (IV) iron preparations should ideally be capable of delivering a wide dosing range to allow iron correction in a single or low number of visits, a rapid infusion (doses up to 1,000 mg must be administered over more than 15 minutes and doses exceeding 1,000 mg must be administered ove...
Uloženo v:
| Vydáno v: | Int J Nephrol Renovasc Dis |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4790490/ https://ncbi.nlm.nih.gov/pubmed/27022297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S89704 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|